Orchestra BioMed Holdings Inc.
Statements
Cash Flow
Orchestra BioMed Holdings Inc. (OBIO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -49 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| -26 | -19 | -29 | -46 | -51 | -49 | |
| 0.1 | 0.2 | 0.2 | 0.3 | 0.3 | 0.3 | |
| 0.2 | 0.3 | 3.4 | 7.6 | 11 | 12 | |
| 3.2 | 0.6 | – | – | – | – | |
| -8.1 | 2.6 | -0.5 | -3.3 | -0.8 | -10 | |
| 0.5 | 0.3 | 0.6 | 0.1 | 0.3 | 0.5 | |
| 27 | 13 | -64 | 11 | 13 | -27 | |
| – | – | -93 | – | – | – | |
| 10 | -4.0 | 3.6 | -11 | 15 | 0.0 | |
| 10 | -4.0 | 103 | 46 | 29 | 88 | |
| 11 | -10 | 9.8 | 11 | -8.3 | 12 | |
| -27 | -20 | -30 | -46 | -51 | -49 |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.